IMC Chicago’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Sell
125,200
-45,600
-27% -$794K ﹤0.01% 2295
2025
Q4
$2.01M Buy
170,800
+70,100
+70% +$900K ﹤0.01% 2417
2025
Q3
$1.6M Sell
100,700
-13,100
-12% -$190K ﹤0.01% 2395
2025
Q2
$1.3M Buy
113,800
+43,500
+62% +$490K ﹤0.01% 2297
2025
Q1
$951K Sell
70,300
-56,100
-44% -$932K ﹤0.01% 2304
2024
Q4
$2.14M Buy
126,400
+40,000
+46% +$778K ﹤0.01% 1824
2024
Q3
$1.76M Buy
86,400
+45,500
+111% +$930K ﹤0.01% 1754
2024
Q2
$923K Sell
40,900
-32,200
-44% -$843K ﹤0.01% 2007
2024
Q1
$1.92M Buy
+73,100
New +$2.08M ﹤0.01% 1380

Other funds holding CC

IMC Chicago's CC Position: Q1 2026 in Review

IMC Chicago increased its Chemours (CC) stake by 175% in Q1 2026, buying an estimated $1.49M and bringing the position to 134,408 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

IMC Chicago first reported a position in CC in Q1 2024 and has held it in 6 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • IMC Chicago held 134,408 shares of Chemours worth $2.96M as of Q1 2026.
  • IMC Chicago bought 85,485 Chemours shares in Q1 2026, an estimated $1.49M.
  • Chemours made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2234 holding.
  • IMC Chicago first reported a position in Chemours in Q1 2024 and has held it in 6 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.